These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2662103)

  • 1. Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein.
    Sramek SJ; Wallow IH; Stevens TS; Nork TM
    Ophthalmology; 1989 Jun; 96(6):835-41. PubMed ID: 2662103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
    Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
    Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of cellular fibronectin in preretinal membranes.
    Ohsato M; Shiga S; Kato H; Hayashi H; Oshima K
    Retina; 1994; 14(5):430-4. PubMed ID: 7899718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical analysis of periretinal membranes. Review and outlook.
    Weller M; Heimann K; Wiedemann P
    Dev Ophthalmol; 1989; 16():54-74. PubMed ID: 2676633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M; Esser P; Heimann K; Wiedemann P
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment.
    Schwatz SD; Alexander R; Hiscott P; Gregor ZJ
    Ophthalmology; 1996 Feb; 103(2):323-8. PubMed ID: 8594521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glial fibrillary acidic protein, actin, fibronectin and factor VIII antigen in human astrocytomas.
    Lolait SJ; Harmer JH; Auteri G; Pedersen JS; Toh BH
    Pathology; 1983 Oct; 15(4):373-8. PubMed ID: 6326028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical study of an eye with proliferative vitreoretinopathy and retinal tacks.
    Nork TM; Wallow IH; Sramek SJ; Stevens TS; De Venecia G
    Retina; 1990; 10(1):78-85. PubMed ID: 1971453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Armstrong D; Augustin AJ; Spengler R; Al-Jada A; Nickola T; Grus F; Koch F
    Ophthalmologica; 1998; 212(6):410-4. PubMed ID: 9787233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular components of proliferative vitreoretinal membranes.
    Kwak SI; Chung H; Lee J
    Korean J Ophthalmol; 1991 Dec; 5(2):68-75. PubMed ID: 1812289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens.
    Zhao F; Gandorfer A; Haritoglou C; Scheler R; Schaumberger MM; Kampik A; Schumann RG
    Retina; 2013 Jan; 33(1):77-88. PubMed ID: 22914684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
    Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.
    Vinores SA; Campochiaro PA; Conway BP
    Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):14-28. PubMed ID: 1688833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
    Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
    Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Augustin AJ; Spitznas M; Koch F; Grus F; Böker T
    Ger J Ophthalmol; 1995 Jan; 4(1):47-51. PubMed ID: 7728110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperconvolution of the inner limiting membrane in vitreomaculopathies.
    Snead DR; Cullen N; James S; Poulson AV; Morris AH; Lukaris A; Scott JD; Richards AJ; Snead MP
    Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):853-62. PubMed ID: 15480733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic preretinal membranes. An immunohistochemical study.
    Jerdan JA; Michels RG; Glaser BM
    Arch Ophthalmol; 1986 Feb; 104(2):286-90. PubMed ID: 3947305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens and lymphocytes in proliferative vitreoretinopathy.
    Proença R; Carvalho M; Proença D; Verissimo J; Regadas I; Travassos A
    Graefes Arch Clin Exp Ophthalmol; 1994 Jan; 232(1):25-32. PubMed ID: 8119598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.